课题基金 / 基金详情

Regulation of the Class Switch Recombination

Regulation of the Class Switch Recombination
类开关重组的调节
批准号:
16590226
负责人:
SUGAI Manabu
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

SUGAI Manabu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The CpG motif in DNA plays a critical role in immunity via modulating the Th1/Th2 balance. In B cells, CpG-containing oligodeoxynucleotides (CpG ODNs) inhibit IL-4-mediated class switch recombination (CSR) to IgG1 and IgE through inhibition of the germline transcription (GLT) of these isotypes. However, the molecular mechanism of this inhibitory effect remains elusive. We showed that Id2 and Bcl6, both of which inhibit IgE GLT and CSR, are not involved in this inhibitory pathway. We demonstrated that there is reduced activity of NFκB binding to the IgE promoter and a reduction of Irf4 protein in CpG ODN-treated B cells. These data indicate the critical role of NFκB and Irf4 in the regulation of IgE CSR through actions downstream of CpG signaling. Unexpectedly, STAT6 activity was not markedly changed by CpG ODN treatment. These results indicate that CpG signals work in various ways to induce Th1-skewed immune responses involving B cells.
期刊论文(67)
专著(0)
科研奖励(0)
会议论文
Roles of phospho-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation.
磷酸化 ERM 和 Rho-ROCK 信号在淋巴细胞极性和尾足形成中的作用。
DOI: --
发表时间: 2004
期刊: J.Cell Biol. 167・2
影响因子: --
作者: [Lee, J.-H.et al.]
通讯作者: J.-H.et al.
DOI: 10.1016/j.bbrc.2004.04.059
发表时间: 2004-06-04
期刊: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子: 3.1
作者: [Nakajima-Nagata, N, Sakurai, T, Shimizu, A]
通讯作者: Shimizu, A
CpG inhibits IgE class switch recombination through suppression of NFkB activity, but not through Id2 or Bcl6.
CpG 通过抑制 NFkB 活性来抑制 IgE 类别转换重组,但不通过 Id2 或 Bcl6 来抑制。
DOI: --
发表时间: 2005
期刊: Biochem.Biophys.Res.Commun. 328
影响因子: --
作者: [Kusunoki, T., Sugai M., Gonda H., Nambu Y., Nagata-Nakajima N., Katakai T., Kusunoki M., Sakamoto A., Tokuhisa T., Nakahata T., Yokota Y., Shimizu A.]
通讯作者: Shimizu A.
DOI: 10.1007/s00109-004-0562-z
发表时间: 2004-06
期刊: Journal of Molecular Medicine
影响因子: --
作者: [M. Sugai;Hiroyuki Gonda;Y. Nambu;Y. Yokota;A. Shimizu]
通讯作者: M. Sugai;Hiroyuki Gonda;Y. Nambu;Y. Yokota;A. Shimizu
17
    Development of new therapies for tumor and autoimmunity using CD8aaT cells
    • 批准号:
      24659148
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      SUGAI Manabu
    • 依托单位:
    Analysis of the functional difference among various Id proteins
    • 批准号:
      21590307
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2009
    • 负责人:
      SUGAI Manabu
    • 依托单位:
    Molecular analysis of ANKH toward gene therapy for TMD
    • 批准号:
      17592073
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2005
    • 负责人:
      SUGAI Manabu
    • 依托单位:
    The roles of E2A and Id2 in class switch recombination
    • 批准号:
      14570104
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.86万
    • 财政年份:
      2002
    • 负责人:
      SUGAI Manabu
    • 依托单位:
    国内基金
    海外基金
    PSG10P/PAX5正反馈环路介导细胞焦亡参与子痫前期发病机制研究
    • 批准号:
      2026JJ81331
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      王楠
    • 依托单位:
    DNA双链断裂抑制Ebf1/Pax5表达导致CD19 CAR-T治疗B-ALL后抗原丢失的机制研究
    • 批准号:
      82370164
    • 项目类别:
      面上项目
    • 资助金额:
      49万元
    • 批准年份:
      2023
    • 负责人:
      陈纯
    • 依托单位:
    从PAX5/SPRR4轴抑制角质形成细胞持续炎症探讨凉血潜阳法在银屑病“瘥后防复”中的分子机制
    • 批准号:
      82374458
    • 项目类别:
      面上项目
    • 资助金额:
      48万元
    • 批准年份:
      2023
    • 负责人:
      李斌
    • 依托单位:
    PAX5调控LINE-1转录影响细胞衰老的机制研究
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      张伟娜
    • 依托单位: